MDA effects on morphophysiology and reproduction of Daphnia magna – preliminary data
DOI:
https://doi.org/10.48797/sl.2023.37Keywords:
PosterAbstract
Background: Psychoactive substances and their metabolites are considered emergent contaminants, raising environmental concerns due to the continuous input into aquatic ecosystems [1]. MDA (3,4-methylenedioxyamphetamine) is a pharmacologically active substance that represents the major metabolite of 3,4-methylenedioxymethamphetamine (MDMA); MDA may be present in MDMA preparations or occur as an illegal psychoactive substance [2]. Considering the possible implementation of MDMA-assisted psychotherapy along with the increased recreational interest in MDA, the presence of MDA in aquatic ecosystems is expected to increase as well as its effects on non-target organisms, including invertebrates [1,3]. Since the ecotoxicological impact of MDA remains unknown, studying its toxic effects on an environmentally relevant organism is most important. Objective: This work aimed to assess the effects of possible MDA-induced toxicity on Daphnia magna through the evaluation of morphophysiological and reproductive endpoints. Methods: Neonates (<24 hours) were exposed to three concentrations of MDA (0.1, 1 and 10 mg/L) for 9 days. Exposures and control were performed with 5 replicates with 20 organisms each. On days 3 and 9, morphophysiological endpoints (body size, heart size and area, and heart rate) and reproductive endpoints (number of ovigerous daphnia and fertility) were determined. In parallel, a standard 21-d reproduction assay was conducted (MDA concentrations: 0, 0.10, 0.18, 0.32, 0.56, 1.00, 1.79 mg/L). Results: Morphophysiological endpoints increased with MDA concentration on the third and ninth day of exposure. An increase in the number of ovigerous daphnia and fecundity was found at 10 mg/L of MDA. In the 21-d assay, MDA caused a significant reduction in fecundity, body size and rate of increase from 0.18 mg/L upwards. Conclusions: Data are suggestive of some adverse influence of MDA on the analyzed endpoints. Nevertheless, other toxicity biomarkers should be evaluated to obtain insight on a mechanistic explanation for the observed effects.
References
1. Fontes MK, Maranho LA, Pereira CDS. Review on the occurrence and biological effects of illicit drugs in aquatic ecosystems. Environ Sci Pollut Res Int, 2020, 27: 30998-31034.
2. Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. J Psychoactive Drugs, 2019, 51: 108-117.
3. Kolaczynska KE, Ducret P, Trachsel D, Hoener MC, Liechti ME, Luethi D. Pharmacological characteriza-tion of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA. Eur Neuropsychopharmacol, 2022, 59: 9-22.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 A. M. Morão, A. R. Carvalho, C. Couto, J. S. Carrola, P. Costa, B. Castro, M. E. Tiritan, C. Ribeiro
This work is licensed under a Creative Commons Attribution 4.0 International License.
In Scientific Letters, articles are published under a CC-BY license (Creative Commons Attribution 4.0 International License), the most open license available. The users can share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as they give appropriate credit, provide a link to the license, and indicate if changes were made (read the full text of the license terms and conditions of use).
The author is the owner of the copyright.